Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

ABT

Abitare In (ABT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT
DataOraFonteTitoloSimboloCompagnia
23/04/200718:00PR Newswire (US)Abbott and Abbott Fund Provide $1 Million to HealthReach to Increase Access to Care and Expand Services at Area's Only Free HealBIT:ABT
02/04/200715:00PR Newswire (US)Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in PsoriasisBIT:ABT
24/03/200717:00PR Newswire (US)Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting CoronaryBIT:ABT
23/03/200722:57PR Newswire (US)Abbott Named to DiversityInc's 'Top 50 Companies for Diversity' ListBIT:ABT
05/03/200716:01PR Newswire (US)Abbott Donates Diagnostic Equipment and Supplies to 16 Clinical Laboratory Programs as Part of 'Labs are Vital(TM)' InitiativeBIT:ABT
22/01/200716:00PR Newswire (US)Abbott Nutrition to Host 'The ZonePerfect(R) Bar' Music Series at 2007 Sundance Film FestivalBIT:ABT
11/01/200714:50PR Newswire (US)Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting Coronary Stent System Launches in EuropeBIT:ABT
14/12/200614:45PR Newswire (US)Abbott Fund Supports Pioneering Malaria Education ProgramBIT:ABT
28/11/200616:15PR Newswire (US)Children Affected by HIV/AIDS Around the World Bring Their Photographs and Stories to Chicago for the First TimeBIT:ABT
23/10/200615:00PR Newswire (US)New Phase III Data Shows Abbott's HUMIRA(R) (Adalimumab) Induced Clinical Remission In Patients With Crohn's Disease Who Lost ReBIT:ABT
22/08/200617:10PR Newswire (US)Rising Medical Costs Biggest Challenge for Diabetes Patients in Managing the ConditionBIT:ABT
02/08/200621:46PR Newswire (US)S&P Equity Research Has Positive View on New Medicare Medical Device Reimbursement RulesBIT:ABT
19/07/200621:00PR Newswire (US)Abbott Announces FDA Clearance of Cell-Dyn Ruby(TM) Hematology InstrumentBIT:ABT
09/05/200615:00PR Newswire (US)Abbott to Present at Banc of America Securities Health Care ConferenceBIT:ABT
28/04/200614:30PR Newswire (US)Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion From European Medicines Agency for the Treatment of Ankylosing SpondyBIT:ABT
11/11/200503:06PR Newswire (US)U.S. District Court Grants Abbott's Request for a Preliminary Injunction Against Biaxin(R) XL GenericsBIT:ABT
31/10/200514:04PR Newswire (US)Abbott Receives FDA Approval for New Kaletra(R) (Lopinavir/Ritonavir) Tablet Formulation for HIV PatientsBIT:ABT
24/08/200514:00PR Newswire (US)Wal-Mart Hosts Child Safety Education Event NationwideBIT:ABT
09/07/200507:21PR Newswire (US)Abbott Statement on Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Ritonavir)BIT:ABT
14/06/200523:00PR Newswire (US)Getting Arms Around Childhood Obesity Focus of Colorado SummitBIT:ABT
10/06/200518:54PR Newswire (US)Abbott Declares 326th Consecutive Quarterly DividendBIT:ABT
12/05/200517:55PR Newswire (US)Recent College Graduates Find Success at AbbottBIT:ABT
27/04/200517:00PR Newswire (US)Creative Way to Calm a Fussy Baby May Win a 'Fuss-Free' Trip For MomBIT:ABT
11/04/200520:00PR Newswire (US)Abbott Named No. 5 to DiversityInc's Top 50 Companies for Diversity listBIT:ABT
05/04/200514:00PR Newswire (US)Abbott Joins National Program to Help Millions of Uninsured Americans Get the Prescription Medicines They NeedBIT:ABT
11/02/200521:12PR Newswire (US)FDA Agrees to File Abbott's New Drug Application for Xinlay(TM) (Atrasentan) to Treat Metastatic Hormone-Refractory Prostate CanBIT:ABT
25/01/200516:00PR Newswire (US)FDA Approves First Gene-Based Test, UroVysion(TM), for Diagnosis of Patients Suspected of Having Bladder CancerBIT:ABT
15/12/200417:55PR Newswire (US)TAP Submits New Drug Application for Febuxostat for the Management of Hyperuricemia in Chronic GoutBIT:ABT
01/11/200417:24PR Newswire (US)Longest Study of Kaletra(R) (Lopinavir/Ritonavir) Based Regimen Demonstrated Favorable Resistance Profile for Patients Through SBIT:ABT
01/11/200416:00PR Newswire (US)/C O R R E C T I O N -- Abbott Laboratories/BIT:ABT
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network